Literature DB >> 17985006

Noninvasive assessment of left-to-right shunting in ventricular septal defects by the proximal isovelocity surface area method on Doppler colour flow mapping.

Mustafa Kosecik1, Gul Sagin-Saylam, Nurettin Unal, Mustafa Kir, Sebnem Paytoncu.   

Abstract

BACKGROUND AND AIM: The proximal isovelocity surface area (PISA), which is the zone of flow convergence appearing on the left ventricular septal surface where flow approaching the defect accelerates, allows quantitative estimation of ventricular septal defect (VSD) flow and defect area on colour Doppler imaging. In the present study, the clinical applicability and reliability of the PISA method in assessing the amount of left-to-right shunting in patients with VSDs were evaluated. PATIENTS AND METHODS: Fifty-eight patients aged 0.25 to 15 years (mean age 4.3+/-4.4 years) with VSDs were prospectively studied. Maximum PISA radius in peak systole (r), peak velocity (V(max)) and velocity time integral (VTI(VSD)) of flow through the VSD were measured. In addition, peak VSD flow (2pir(2) Nyquist limit [NL]), amount of left-to-right shunting (Qp-Qs = heart rate x [2pir(2) x NL x VTI(VSD)]/V(max)) and defect area ([2pir(2) x NL]/V(max)) were calculated.
RESULTS: There were significant positive correlations between Qp-Qs values calculated by PISA and other spectral Doppler methods using the cross-sectional area, as well as the VTI of pulmonary-aortic (r=0.73, P<0.001) or mitral-tricuspid (r=0.58, P<0.001) flows and cardiac catheterization (20 patients, r=0.82, P<0.001). PISA-derived left-to-right-shunting discriminated moderate to large defects from small defects, which were classified according to the catheter-derived Qp/Qs ratio (2 or greater versus less than 2; P=0.001) or clinical evaluation (P<0.001).
CONCLUSIONS: The present study demonstrated that the PISA method is a reliable semiquantitative method to determine the amount of left-to-right shunting of VSDs and to discriminate moderate to large defects from small defects. Consequently, this method may serve as a simple and useful adjunct to conventional spectral Doppler methods in the noninvasive assessment of patients with VSDs.

Entities:  

Mesh:

Year:  2007        PMID: 17985006      PMCID: PMC2651928          DOI: 10.1016/s0828-282x(07)70872-3

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  16 in total

1.  Quantitative assessment of severity of ventricular septal defect by three-dimensional reconstruction of color Doppler-imaged vena contracta and flow convergence region.

Authors:  M Ishii; K Hashino; G Eto; T Tsutsumi; W Himeno; Y Sugahara; H Muta; J Furui; T Akagi; Y Ito; H Kato
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

Review 2.  Doppler echocardiography.

Authors:  C G DeGroff
Journal:  Pediatr Cardiol       Date:  2002 May-Jun       Impact factor: 1.655

3.  Doppler color flow "proximal isovelocity surface area" method for estimating volume flow rate: effects of orifice shape and machine factors.

Authors:  T Utsunomiya; T Ogawa; R Doshi; D Patel; M Quan; W L Henry; J M Gardin
Journal:  J Am Coll Cardiol       Date:  1991-04       Impact factor: 24.094

4.  A new method for quantification of regurgitant flow rate using color Doppler flow imaging of the flow convergence region proximal to a discrete orifice. An in vitro study.

Authors:  F Recusani; G S Bargiggia; A P Yoganathan; A Raisaro; L M Valdes-Cruz; H W Sung; C Bertucci; M Gallati; V A Moises; I A Simpson
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

5.  [Pulmonary to systemic flow ratios in patients with ventricular septal defect: estimation by transmitral flow velocity].

Authors:  S Kurokawa; M Takahashi; Y Kato; J Muramatsu; R Kikawada
Journal:  J Cardiol       Date:  1988-09       Impact factor: 3.159

6.  Validation of the proximal flow convergence method. Calculation of orifice area in patients with mitral stenosis.

Authors:  L Rodriguez; J D Thomas; V Monterroso; A E Weyman; P Harrigan; L N Mueller; R A Levine
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

7.  Effective regurgitant orifice area: a noninvasive Doppler development of an old hemodynamic concept.

Authors:  M Enriquez-Sarano; J B Seward; K R Bailey; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1994-02       Impact factor: 24.094

8.  Two-dimensional echocardiographic determination of ventricular septal defect size: correlation with autopsy.

Authors:  D S Sharif; J C Huhta; P Marantz; H K Hawkins; G Y Yoon
Journal:  Am Heart J       Date:  1989-06       Impact factor: 4.749

9.  Hemodynamic correlates of clinical severity in isolated ventricular septal defect.

Authors:  S S Gidding; M Bessel
Journal:  Pediatr Cardiol       Date:  1993-07       Impact factor: 1.655

10.  Noninvasive evaluation of left-to-right shunts by pulsed Doppler echocardiography.

Authors:  F Cacciapuoti; M Varricchio; M D'Avino; G D'Angelo; S Gentile; D Lama; M Cotrufo
Journal:  Int J Cardiol       Date:  1986-10       Impact factor: 4.164

View more
  3 in total

1.  Relationships between left heart chamber dilatation on echocardiography and left-to-right ventricle shunting quantified by cardiac catheterization in children with ventricular septal defects.

Authors:  Selman Gokalp; Ayse Guler Eroglu; Levent Saltik; Bulent Koca
Journal:  Pediatr Cardiol       Date:  2013-11-21       Impact factor: 1.655

2.  Clinical utility of the ventricular septal defect diameter to aorta root diameter ratio to predict early childhood developmental defects or lung infections in patients with perimembranous ventricular septal defect.

Authors:  Jin-Xiang Liu; Jing-Hua Wang; Si-Rui Yang; Min Liu; Yang Xu; Jing-Hui Sun; Chao-Ying Yan
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

3.  Can intraoperative TEE correctly measure residual shunt after surgical repair of ventricular septal defects?

Authors:  Satoshi Kurokawa; Takayuki Honma; Miki Taneoka; Hidekazu Imai; Hiroshi Baba; Minoru Nomura
Journal:  J Anesth       Date:  2010-03-13       Impact factor: 2.078

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.